Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1961 1
1966 1
1967 1
1969 2
1970 3
1971 1
1972 1
1973 2
1974 1
1976 2
1977 1
1978 1
1979 1
1980 4
1981 2
1982 5
1983 1
1984 3
1985 4
1986 5
1987 5
1988 5
1989 13
1990 9
1991 8
1992 5
1993 6
1994 9
1995 6
1996 4
1997 8
1998 11
1999 14
2000 14
2001 22
2002 17
2003 14
2004 15
2005 25
2006 17
2007 28
2008 25
2009 38
2010 38
2011 31
2012 28
2013 32
2014 50
2015 39
2016 40
2017 37
2018 56
2019 45
2020 65
2021 72
2022 69
2023 54
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

912 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA).
Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K, Hatano E, Nagano H; Kansai Hepatobiliary Oncology Group (KHBO). Ioka T, et al. Among authors: kamei k. J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110. doi: 10.1002/jhbp.1219. Epub 2022 Aug 9. J Hepatobiliary Pancreat Sci. 2023. PMID: 35900311 Free PMC article. Clinical Trial.
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K; Japanese Study Group of Kidney Disease in Children. Iijima K, et al. Among authors: kamei k. J Am Soc Nephrol. 2022 Feb;33(2):401-419. doi: 10.1681/ASN.2021050643. Epub 2021 Dec 8. J Am Soc Nephrol. 2022. PMID: 34880074 Free PMC article. Clinical Trial.
New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation.
Asano K, Hebisawa A, Ishiguro T, Takayanagi N, Nakamura Y, Suzuki J, Okada N, Tanaka J, Fukutomi Y, Ueki S, Fukunaga K, Konno S, Matsuse H, Kamei K, Taniguchi M, Shimoda T, Oguma T; Japan ABPM Research Program. Asano K, et al. Among authors: kamei k. J Allergy Clin Immunol. 2021 Apr;147(4):1261-1268.e5. doi: 10.1016/j.jaci.2020.08.029. Epub 2020 Sep 10. J Allergy Clin Immunol. 2021. PMID: 32920094 Free article.
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Kohno S, Izumikawa K, Takazono T, Miyazaki T, Yoshida M, Kamei K, Ogawa K, Taniguchi S, Akashi K, Tateda K, Mukae H, Miyazaki Y, Okada F, Kanda Y, Kakeya H, Suzuki J, Kimura SI, Kishida M, Matsuda M, Niki Y. Kohno S, et al. Among authors: kamei k. J Infect Chemother. 2023 Feb;29(2):163-170. doi: 10.1016/j.jiac.2022.10.010. Epub 2022 Oct 25. J Infect Chemother. 2023. PMID: 36307059 Free article. Clinical Trial.
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.
Chan EY, Yu ELM, Angeletti A, Arslan Z, Basu B, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Drovandi S, Ghiggeri GM, Gipson DS, Hamada R, Hogan J, Ishikura K, Kamei K, Kemper MJ, Ma AL, Parekh RS, Radhakrishnan S, Saini P, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Yap HK, Tullus K. Chan EY, et al. Among authors: kamei k. J Am Soc Nephrol. 2022 Jun;33(6):1193-1207. doi: 10.1681/ASN.2021111472. Epub 2022 Mar 30. J Am Soc Nephrol. 2022. PMID: 35354600 Free PMC article.
Editorial: Materials for mechanotransduction and beyond.
Sonam S, Malmstrom J, Kamei KI, Dalby MJ. Sonam S, et al. Among authors: kamei ki. Front Cell Dev Biol. 2023 May 26;11:1222957. doi: 10.3389/fcell.2023.1222957. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37305678 Free PMC article. No abstract available.
A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants.
Malakasioti G, Iancu D, Milovanova A, Tsygin A, Horinouchi T, Nagano C, Nozu K, Kamei K, Fujinaga S, Iijima K, Sinha R, Basu B, Morello W, Montini G, Waters A, Boyer O, Yıldırım ZY, Yel S, Dursun İ, McCarthy HJ, Vivarelli M, Prikhodina L, Besouw MTP, Chan EY, Huang W, Kemper MJ, Loos S, Prestidge C, Wong W, Zlatanova G, Ehren R, Weber LT, Chehade H, Hooman N, Tkaczyk M, Stańczyk M, Miligkos M, Tullus K; CNI in Monogenic SRNS Study Investigators. Malakasioti G, et al. Among authors: kamei k. Kidney Int. 2023 May;103(5):962-972. doi: 10.1016/j.kint.2023.02.022. Epub 2023 Mar 8. Kidney Int. 2023. PMID: 36898413
912 results